A wearable 3-lead ECG device with dual HCM indices and statistical thresholds distinguishes hypertrophic cardiomyopathy from acquired LVH at 75.86% sensitivity and 99.17% specificity on 29 HCM and 483 LVH cases.
Bringing MRI to low- and middle-income countries: directions, challenges and potential solutions
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
eess.IV 1years
2026 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
A Wearable ECG Device for Differentiating Hypertrophic Cardiomyopathy from Acquired Left Ventricular Hypertrophy
A wearable 3-lead ECG device with dual HCM indices and statistical thresholds distinguishes hypertrophic cardiomyopathy from acquired LVH at 75.86% sensitivity and 99.17% specificity on 29 HCM and 483 LVH cases.